2invest AG (FRA:2INV)
Germany · Delayed Price · Currency is EUR 8.20
-0.14 (-1.68%)
At close: Jul 10, 2026
2invest AG Market Cap
2invest AG has a market cap or net worth of €45.07 million as of July 15, 2026. Its market cap has decreased by -31.89% in one year.
Market Cap
45.07M
Enterprise Value
24.52M
Revenue
n/a
Ranking
n/a
PE Ratio
13.26
Stock Price
€8.20
Market Cap Chart
Since December 7, 2012, 2invest AG's market cap has increased from 35.90M to 45.07M, an increase of 25.54%. That is a compound annual growth rate of 1.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 45.07M | -28.30% |
| Dec 30, 2025 | 62.87M | -5.72% |
| Dec 30, 2024 | 66.68M | 65.71% |
| Dec 29, 2023 | 40.24M | -19.72% |
| Dec 30, 2022 | 50.12M | -32.92% |
| Dec 30, 2021 | 74.73M | -18.39% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 84.60M |
| Biomark Diagnostics | 33.65M |
| Vidac Pharma Holding | 24.42M |
| Paion AG | 428.02K |
| co.don AG | 334.04K |
| bioXXmed AG | 209.34K |
| MagForce AG | 91.72K |